Publications by authors named "F B Nava"

Introduction: Systemic sclerosis (SSc) is a chronic autoimmune disease characterized by fibrosis and vascular abnormalities, often leading to the development of digital ulcers (DUs). DUs are painful and debilitating, significantly impacting patients' quality of life. Effective pain management during debridement is crucial, yet there is no consensus on the optimal approach.

View Article and Find Full Text PDF

Immunosuppression is essential to ensure recipient and graft survivals after liver transplantation (LT). However, our understanding and management of the immune system remain suboptimal. Current immunosuppressive therapy cannot selectively inhibit the graft-specific immune response and entails a significant risk of serious side effects, i.

View Article and Find Full Text PDF
Article Synopsis
  • Italy has the highest rates of hepatitis C virus (HCV) infection and liver cancer deaths in Europe, but new treatments have expanded access, with over 244,000 people treated.
  • While HCV-related deaths are expected to drop by 75% by 2030, Italy is at risk of not eliminating HCV completely by that time.
  • To improve HCV elimination efforts, recommendations include expanding screening to more populations, raising awareness, ensuring continued access to direct-acting antivirals, and customizing care for high-risk groups.
View Article and Find Full Text PDF

Purpose: Hepatitis C virus (HCV) spreads from contact with blood of an infected person. HCV infections are common among people who use drugs (PWUDs), when sharing needles, syringes, or other equipment for injected drugs. The advent of pangenotypic direct-antiviral agents (DAA) in 2017 transformed the treatment landscape for HCV, but PWUDs remain a complex and hard-to-treat population with high risk of HCV reinfection.

View Article and Find Full Text PDF

Cooperation is one of the most advantageous strategies to have evolved in small- and large-scale human societies, often considered essential to their success or survival. We investigated how cooperation and the mechanisms influencing it change across the lifespan, by assessing cooperative choices from adolescence to old age (12-79 years, N = 382) forcing participants to decide either intuitively or deliberatively through the use of randomised time constraints. As determinants of these choices, we considered participants' level of altruism, their reciprocity expectations, their optimism, their desire to be socially accepted, and their attitude toward risk.

View Article and Find Full Text PDF